Topical 0.01% Atropine for the Control of Fast Progressing Myopia

NCT04173780 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

60

Enrollment

OTHER

Sponsor class

Stopped recruitment difficulties

Conditions

Myopia Progressing
Childhood

Interventions

DRUG: Atropine 0.01%
DRUG: Placebo

Sponsor

University Hospital, Strasbourg, France